Importer of Controlled Substances; Notice of Registration, 65749-65750 [2011-27430]

Download as PDF 65749 Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices JUDICIAL CONFERENCE OF THE UNITED STATES Hearing of the Judicial Conference Committee on Civil Rules Judicial Conference of the United States, Advisory Committee on Civil Rules. ACTION: Notice of cancellation of open hearing. AGENCY: The following public hearing on proposed amendments to the Federal Rules of Civil Procedure has been canceled: Civil Rules Hearing, November 7, 2011, in Washington, DC. FOR FURTHER INFORMATION CONTACT: Benjamin J. Robinson, Deputy Rules Officer and Counsel, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. SUMMARY: BILLING CODE 2210–55–P DEPARTMENT OF JUSTICE Antitrust Division tkelley on DSK3SPTVN1PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—DVD Copy Control Association Notice is hereby given that, on August 26, 2011, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), DVD Copy Control Association (‘‘DVD CCA’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, NEC USA, Inc., New York, NY; Chicovery Co., Ltd., San Chung City, Taipei, Taiwan; Meiloon Industrial Co., Ltd., Taoyuan City, Taiwan; MIT Technology Co., Ltd., Dongguan, Guangdong, People’s Republic of China; and IMS International Media Service S.p.A., Varese, Italy, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and DVD CCA intends to file additional written Jkt 226001 [FR Doc. 2011–27215 Filed 10–21–11; 8:45 am] BILLING CODE M DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993—TAI and Southwest Research Institute [FR Doc. 2011–27419 Filed 10–21–11; 8:45 am] 15:34 Oct 21, 2011 Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. Antitrust Division Dated: October 18, 2011. Benjamin J. Robinson, Deputy Rules Officer and Counsel. VerDate Mar<15>2010 notifications disclosing all changes in membership. On April 11, 2001, DVD CCA filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on August 3, 2001 (66 FR 40727). The last notification was filed with the Department on June 23, 2011. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 20, 2011 (76 FR 43348). Notice is hereby given that, on August 24, 2011, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), TAI and SwRI Consortium for Advanced Research for the Development of Telecommunication and Security Tools (‘‘TAISR’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objective of the venture. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Southwest Research Institute, San Antonio, TX, and Tridex Associates, Inc., Woodbridge, VA. The general area of TAISR’s planned activities is to advance the field of security and telecommunications tools research and development by organizing and implementing joint engineering and scientific research activities. These activities will encompass the development of sophisticated telecommunication tools and or components in the engineering and scientific areas of electronic systems, hardware design, packaging and rapid prototyping. Membership in this research group is closed, and the participants intend to file additional written notification PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 disclosing all changes in planned activities. Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2011–27114 Filed 10–21–11; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated August 9, 2011, and published in the Federal Register on August 18, 2011, 76 FR 51399, Aptuit, 10245 Hickman Mills Drive, Kansas City, Missouri 64137, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Marihuana (7360) ......................... Poppy Straw Concentrate (9670) Schedule I II The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form for packaging for a clinical trial study. In addition, the company also plans to import an ointment for the treatment of wounds which contains trace amounts of the controlled substances normally found in poppy straw concentrate for packaging and labeling for clinical trials. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Aptuit to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Aptuit to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of E:\FR\FM\24OCN1.SGM 24OCN1 65750 Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices the basic classes of controlled substances listed. Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–27430 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 7, 2011, and published in the Federal Register on June 16, 2011, 76 FR 35243, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug tkelley on DSK3SPTVN1PROD with NOTICES Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. (Pub. L. 94–409) (5 U.S.C. 552b) [FR Doc. 2011–27424 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE I Advisory Board Meeting Time and Date: 8 a.m. to 4:30 p.m. on Wednesday, November 2, 2011, 8 a.m. to 4:30 p.m. on Thursday, November 3, 2011. Place: Stanford University Law School, 550 Nathan Abbott Way, Stanford, California, (650) 724–6258. Matters To Be Considered: Organizational culture and change in the correctional environment; Performance Based Outcomes; Director’s report; Presentations. Contact Person for More Information: Thomas Beauclair, Deputy Director, 202–307–3106, ext. 44254. I I II II II II II II II II II II II II II II II II Morris L. Thigpen, Director. [FR Doc. 2011–27157 Filed 10–21–11; 8:45 am] BILLING CODE 4410–36–M II II II II II II Jkt 226001 DEPARTMENT OF JUSTICE United States Parole Commission Sunshine Act Meeting; Record of Vote of Meeting Closure I, Isaac Fulwood, of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 11 a.m., on Thursday, September 8, 2011, at the U.S. Parole Commission, 90 K Street, PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Dated: September 15, 2011. Isaac Fulwood, Chairman, U.S. Parole Commission. [FR Doc. 2011–27571 Filed 10–20–11; 4:15 pm] National Institute of Corrections I I I I I The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of 15:34 Oct 21, 2011 NE., Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss four original jurisdiction cases pursuant to 28 CFR 2.27. Four Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Isaac Fulwood, Cranston J. Mitchell, Patricia Cushwa and J. Patricia Wilson Smoot. Schedule Gamma Hydroxybutyric Acid (2010). Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Dimethyltryptamine (7435) ........... 1-[1-(2-Thienyl) cyclohexyl] piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Amobarbital (2125) ....................... Phencyclidine (7471) .................... Phenylacetone (8501) .................. Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Heroin (9200) ............................... Meperidine (9230) ........................ Metazocine (9240) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Phenazocine (9715) ..................... Fentanyl (9801) ............................ VerDate Mar<15>2010 American Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–01–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (11–105)] Aerospace Safety Advisory Panel; Charter Renewal National Aeronautics and Space Administration (NASA). ACTION: Notice of renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel. AGENCY: Pursuant to sections 14(b)(1) and 9(c) of the Federal Advisory Committee Act (Pub. L. 92–463), and after consultation with the Committee Management Secretariat, General Services Administration, the NASA Administrator has determined that a renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel is in the public interest in connection with the performance of duties imposed on NASA by law. The renewed charter is for a two-year period ending October 13, 2013. It is identical to the previous charter in all respects except it removes references to areas of responsibility that are no longer applicable, updates legal citations, and conforms the text to the most recent Congressional reauthorization for this Federal advisory committee (Pub. L. 111–314 on December 18, 2010). SUMMARY: E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 76, Number 205 (Monday, October 24, 2011)]
[Notices]
[Pages 65749-65750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27430]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated August 9, 2011, and published in the Federal 
Register on August 18, 2011, 76 FR 51399, Aptuit, 10245 Hickman Mills 
Drive, Kansas City, Missouri 64137, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import a finished pharmaceutical product 
containing cannabis extracts in dosage form for packaging for a 
clinical trial study. In addition, the company also plans to import an 
ointment for the treatment of wounds which contains trace amounts of 
the controlled substances normally found in poppy straw concentrate for 
packaging and labeling for clinical trials.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and 
determined that the registration of Aptuit to import the basic classes 
of controlled substances is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Aptuit to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of

[[Page 65750]]

the basic classes of controlled substances listed.

    Dated: October 3, 2011.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-27430 Filed 10-21-11; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.